Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that Dr Yen Choo, the company’s Chief Executive, has been appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines.

Dr Choo is the first member of the Committee recruited from the biotechnology industry – he joins experts in science, medicine, ethics and theology as well as lay members and representatives from regulatory and funding agencies.

“The Steering Committee and its published ‘Code of Practice for the use of Human Stem Cell Lines’ are globally acclaimed regulatory models that have greatly helped the UK secure a leading position in the field” said Dr Choo. “I look forward to serving on the Committee and to helping lay the foundations for the translation of this research into pioneering therapies for serious diseases”.